A major push to sharpen the future of cancer treatment is underway
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
The Stealth AXiS surgical navigation system was recently cleared by the US Food and Drug Administration (FDA) for cranial procedures in the United States
The device aims to bring precision neuroscience into clinical trials, accelerating drug development
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
Subscribe To Our Newsletter & Stay Updated